AI Article Synopsis
- Eso-SPONGE® is an effective treatment for persistent leaks at the esophagogastric connection after subtotal esophagectomy, particularly useful in high-risk patients.
- A case study of a 72-year-old man with esophageal adenocarcinoma demonstrated that the therapy significantly reduced inflammation and promoted healing after several sessions.
- The therapy is easy to administer in specialized centers, making it a valuable option for managing esophageal complications post-surgery.
Article Abstract
Introduction: Eso-SPONGE® has proved to be an excellent method for the treatment of persistent dehiscence of the intrathoracic esophagogastric anastomosis during the operation of subtotal esophagectomy sec. Ivor Lewis.
Clinical Case Presentation: The case presented is of a 72-year-old patient with esophageal adenocarcinoma (ADK) who underwent sub-total esophagectomy and esophagoplasty sec. Ivor Lewis complicated by an esophageal leak. The Eso-SPONGE® therapy has been successful halving the index of inflammation after the first two sessions and generation of a neowall after seven sessions.
Discussion: Eso-SPONGE® therapy has proven to be a valuable resource as a treatment for esophageal anastomotic dehiscences because it is easily repeatable in suburban centers, provided that they have a digestive endoscopy specialized in the positioning process.
Conclusions: Eso-SPONGE® is a minimally invasive method that delivers excellent results in the treatment of fragile patients, such as those who have post-esophageal anastomotic dehiscence.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8536516 | PMC |
| http://dx.doi.org/10.1016/j.ijscr.2021.106525 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!